Quality and Responsible Research
Our operational commitment to scientific rigor, contemporaneous documentation, participant confidentiality, and proactive risk oversight.
A Responsible, Evidence-Guided Approach to Clinical Operations
ResearchPath recognizes that clinical research directly impacts participant well-being and public health outcomes. We structure our operational support to mirror internationally accepted ethical and scientific norms. We do not claim unilateral formal accreditation or third-party certifications; rather, we execute our work within the explicit protocol parameters, Institutional Ethics Committee mandates, and standard operating procedures agreed upon with trial sponsors and investigator sites.
Contemporaneous & Audit-Ready Documentation
In clinical research, documentation is the verified mirror of study conduct. ResearchPath trains its operational personnel to apply ALCOA+ principles across all site coordination and data management activities:
- Attributable: Every record, note, and query resolution clearly identifies who executed the action.
- Legible & Contemporaneous: Data entries are recorded in real-time at the time of observation or visit execution.
- Original & Accurate: Source records are maintained as pristine first recordings or certified copies without undocumented corrections.
Documentation Quality Checks
We perform routine documentation reconciliations between Investigator Site Files (ISF) and Trial Master Files (TMF) to catch version discrepancies or missing acknowledgments before formal sponsor monitoring or authority audits take place.
• Site Delegation & Signature Logs
• Ethics Committee Approval & Amendment Dossiers
• Source Document Worksheets & eCRF Tracking
Confidentiality & Participant Safeguards
Participant trust is paramount. All operational support services provided by ResearchPath are executed under strict data privacy principles designed to protect Protected Health Information (PHI):
- Subject Pseudonymization: Unique identifier codes are used across all operational documentation. Direct personal identifiers never leave the site.
- Role-Based Access: Only authorized operational personnel assigned to the investigator delegation log access study records.
- NDA Execution: Strict non-disclosure covenants protect proprietary sponsor study synopses, protocols, and investigator insights.
Data Security Protocols
Our digital workflows mandate encrypted data transfer channels, secure credential management, and zero local caching of sensitive trial data on personal devices.
• Zero public transmission of patient medical records
• Physical separation of master enrollment logs at site
• Transparent incident logging and escalation
Risk Awareness & Continuous Quality Review
Rather than treating quality as an afterthought, we apply risk-based thinking throughout the operational lifecycle:
- Early Roadblock Detection: Identification of screening bottlenecks, supply chain lags, or appointment scheduling conflicts.
- Root Cause Analysis (RCA): Analyzing protocol deviations to implement systemic corrections rather than treating isolated symptoms.
- Collaborative Checkpoints: Weekly or bi-weekly operational alignment meetings with sponsors and investigators to review deliverable metrics.
Transparency Commitment
When operational deviations or protocol hurdles emerge, we escalate them immediately to the Principal Investigator and sponsor trial managers with transparent documentation and proposed corrective options.
• Standardized Deviations Tracking Registers
• Pre-Monitoring Visit Readiness Checklists
• Corrective and Preventive Action (CAPA) Logs
Have Questions About Our Quality Framework?
We welcome the opportunity to discuss our operational workflows, standard documentation trackers, and quality review practices for your study.